about
Focus on Extracellular Vesicles: Physiological Role and Signalling Properties of Extracellular Membrane VesiclesPathophysiology and neuroprotection of global and focal perinatal brain injury: lessons from animal modelsHyperbaric oxygen preconditioning: a reliable option for neuroprotectionSystematic review and stratified meta-analysis of the efficacy of carnosine in animal models of ischemic strokeSac-1004, a vascular leakage blocker, reduces cerebral ischemia-reperfusion injury by suppressing blood-brain barrier disruption and inflammation.The Effect of Pre-Condition Cerebella Fastigial Nucleus Electrical Stimulation within and beyond the Time Window of Thrombolytic on Ischemic Stroke in the Rats.Effect of Long-Term Treatment with Fimasartan on Transient Focal Ischemia in Rat Brain.Therapeutics targeting the inflammasome after central nervous system injury.Prefrontal Ischemia in the Rat Leads to Secondary Damage and Inflammation in Remote Gray and White Matter Regions."Zipped Synthesis" by Cross-Metathesis Provides a Cystathionine β-Synthase Inhibitor that Attenuates Cellular H2S Levels and Reduces Neuronal Infarction in a Rat Ischemic Stroke Model.Vectorized nanodelivery systems for ischemic stroke: a concept and a need.Integrative intervention: a new perspective and brief review in aphasia.The interplay of microRNAs and post-ischemic glutamate excitotoxicity: an emergent research field in stroke medicine.Low dose Hsp90 inhibitor 17AAG protects neural progenitor cells from ischemia induced death.Parecoxib Protects Mouse Cortical Neurons Against OGD/R Induced Neurotoxicity by Up-Regulating Bcl-2.Neuroprotection of Catalpol for Experimental Acute Focal Ischemic Stroke: Preclinical Evidence and Possible Mechanisms of Antioxidation, Anti-Inflammation, and Antiapoptosis.Sulforaphane exerts neuroprotective effects via suppression of the inflammatory response in a rat model of focal cerebral ischemia.Modulation of mitochondrial function and autophagy mediates carnosine neuroprotection against ischemic brain damage.Pseudoginsenoside-F11 attenuates cerebral ischemic injury by alleviating autophagic/lysosomal defects.Integrated treatment modality of cathodal-transcranial direct current stimulation with peripheral sensory stimulation affords neuroprotection in a rat stroke model.Condition-specific transcriptional regulation of neuronal ion channel genes in brain ischemia.Ethanol Iris tenuifolia extract reduces brain damage in a mouse model of cerebral ischaemia.Implantable systems for drug delivery to the brain.Soluble or soluble/membrane TNF-α inhibitors protect the brain from focal ischemic injury in rats.Neuroprotective Effects of Poly(ADP-ribose)polymerase Inhibitor Olaparib in Transient Cerebral Ischemia.Xingnaojing mPEG2000-PLA modified microemulsion for transnasal delivery: pharmacokinetic and brain-targeting evaluation.It's All about Timing: The Involvement of Kir4.1 Channel Regulation in Acute Ischemic Stroke Pathology.S1PR3 is essential for phosphorylated fingolimod to protect astrocytes against oxygen-glucose deprivation-induced neuroinflammation via inhibiting TLR2/4-NFκB signalling.The Role of Magnesium in Neurological Disorders.
P2860
Q26767270-6F9BE7CB-7EF5-4A14-A4A3-CB7A11833087Q27000069-FB1C60E8-214F-4804-936C-27433C0CE693Q28069280-D0EDB5E2-5CB8-4488-92BD-247EF4E0208EQ28073784-9150AE21-245C-4AA4-9479-6043D3D6683DQ33827436-A43B5140-119B-4178-B9CD-B99C525268A7Q35643103-AFD50DC2-E0B0-4557-A925-920D293AD016Q36095573-8A81C4EF-8E78-436D-9B39-356BF8E37BAFQ36275988-D3A32C67-2BDF-45D3-81CC-C812224113F2Q36637202-EDCB3F0A-F1B8-493E-8D80-5CB7C85AFE89Q36850630-51CBC3F1-6CEE-4C76-90A6-D81ACEA16CBCQ38731765-34FD371E-854A-4588-84F6-CDEA3AB054EBQ38827070-43298033-850B-4072-B589-AC373EF080C4Q38879224-4FB96E89-CE7C-487E-BEB0-F18DDD91B8CFQ39426384-5663F5E6-1D5B-4F0A-8110-EBE1BC24CAD3Q40879701-CA0E74D7-9097-4101-B087-C7D95C538CA2Q41146524-FC3FF009-9428-443F-9543-A783D304C471Q41574946-65A9D59F-B42E-4CC6-AC25-F2AB6ACD5823Q41827290-C0A0683C-4C48-4C0F-9B87-7BEBB83AC811Q41912784-D07A836D-9E63-4507-B123-8FFFD582F69BQ47578329-DFF901EE-DE7E-4587-8CCF-B594AA99E2C8Q47852935-38E69E1C-8032-4BBC-BD21-679397F7ECAAQ47954024-03CAF1AD-30B4-4986-9AC2-53B438C214FEQ47975817-97889B30-B104-44B6-9D76-D7D448646327Q48473077-74EC0FAD-607F-4A9F-BC6A-BA0821D978EEQ48912898-4DC7353E-DB29-4C89-920C-87915EDEA378Q52147484-DB0BC622-3138-437B-BF23-24BC48D8C3C9Q54951068-0D0E0965-CB91-4389-9662-1F2DDC579083Q54982164-3B4067AE-A878-403C-BA77-BD8BA55DF4BCQ55515107-C709F4A9-68E8-4B94-86BC-2BD335F7821E
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neuroprotection in stroke: past, present, and future.
@en
Neuroprotection in stroke: past, present, and future.
@nl
type
label
Neuroprotection in stroke: past, present, and future.
@en
Neuroprotection in stroke: past, present, and future.
@nl
prefLabel
Neuroprotection in stroke: past, present, and future.
@en
Neuroprotection in stroke: past, present, and future.
@nl
P2860
P356
P1433
P1476
Neuroprotection in stroke: past, present, and future.
@en
P2093
Arshad Majid
P2860
P304
P356
10.1155/2014/515716
P577
2014-01-21T00:00:00Z